All Industry articles
View all stories with this category.
-
OpinionDo science courses need hands-on labs to be effective?
The practical lab is where abstract theory connects to physical reality
-
Business
Arrayit chief convicted of fraud over blood testing
Mark Schena misrepresented the company’s value to investors and defrauded public and private insurers
-
Business
Nature-inspired crop protection
Plant extracts, proteins and pheromones aiming to replace conventional chemical pesticides
-
Business
Rocket-powered carbon dioxide conversion
Barton Blakeley is lowering the carbon footprint of silica and other materials
-
Business
J&J to phase out talc-based baby powder worldwide
In the face of thousands of lawsuits, firm will switch to cornstarch-based formulations
-
Business
Protective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
Opinion
Why AlphaFold won’t revolutionise drug discovery
Protein structure prediction is a hard problem, but even harder ones remain
-
Business
UK Reach costs stretch higher for industry
Government assessment suggests deadlines will be delayed and companies will pay billions for compliance data
-
News
Software from Cambridge crystallographic experts could save pharma industry millions
Informatic tools will help drug formulators understand particle behaviour in their final product
-
Opinion
May cause side effects
The dose makes the poison, but understanding unwanted drug interactions is complicated
-
News
US chemical industry responsible for 25% of the country’s GDP
National Academies finds chemical research has ‘outsized economic value’
-
Business
Chemours sues over US PFAS safety limit
Fluoropolymer maker appeals new safety standard for GenX, calling it ‘scientifically unsound’
-
Business
Gas shortage puts pressure on chemical feedstocks
Demand for fuels has constricted European supplies, pushing up prices and threatening rationing
-
Business
Haleon emerges from GSK consumer healthcare spin-off
Split illustrates move towards narrower focus in pharmaceuticals
-
Sponsored
Making quality the priority for fine and specialty chemicals suppliers
Precision measurements and data integrity are essential in pharma and cosmetics supply chains
-
Business
California advances plans to make its own insulin
Governor commits $100 million to develop low-cost insulin and build manufacturing facility to strengthen drug’s supply chain
-
Business
Second Theranos executive convicted of fraud
Blood testing startup president Ramesh ‘Sunny’ Balwani defrauded both investors and patients
-
Business
Novartis cutting up to 8000 jobs
Restructure splits commercial activities geographically instead of by treatment area
-
Business
US reinstates Superfund taxes to clean up 1300 contaminated sites
Levy on 42 chemicals and their derivatives aims to revive neglected cleanup programme
-
Opinion
Alzheimer’s, amyloid and abandoned antibodies
Biogen’s aducanumab is stumbling into obscurity. Where does that leave the amyloid hypothesis?
